Abstract
Genetic studies of calcium kidney stones have hitherto assessed single candidate genes by testing for linkage disequilibria or associations between a locus and stone disease. They have identified the potential involvement of the calcium-sensing receptor (CaSR), vitamin D receptor, (VDR), and bicarbonate-sensitive adenylyl cyclase genes. In addition to research in humans, studies on different strains of knock-out mice have enabled us to include the phosphate reabsorption carrier NPT2 gene, the caveolin-1 gene, the protein NHERF-1 gene modulating calcium and urate reabsorption, osteopontin, and Tamm–Horsfall protein among the possible determinants. Interactions between genes, and between environmental factors and genes, are generally considered fundamental to calcium stone formation, however. To date, therefore, genetic studies have failed to significantly advance our understanding of the causes of calcium kidney stones, though they have enabled us to assess the dimension of the problem and establish criteria for facing it. Further progress in our knowledge of what causes calcium stones may derive from using the tools afforded to researchers by modern biotechnology and bioinformatics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hodkinson A, Pyrah LN. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stones of renal origin. Brit J Surg. 1958;46:10-18.
Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment and the value of prospective cohort studies. Nature Rev Genet. 2006;7:812-820.
Colhourn HM, McKeigue PM, Smith JD. Problems of reporting genetics associations with complex outcomes. Lancet. 2003;361: 865-872.
Loredo-Osti JC, Roslin NM, Tessier J, et al. Segregation of urine calcium excretion in families ascertained for nephrolithiasis: evidence for a major gene. Kidney Int. 2005;68:966-971.
Lander ES, Schork NJ. Gentic dissection of complex traits. Science. 1994;265:2037-2048.
Scott P, Ouimet D, Proulx Y, et al. The 1 alpha hydroxylase locus is not linked to calcium stone formation or calciuric phenotype in French-Canadian families. J Am Soc Nephrol. 1998;9:425-432.
Scott P, Ouimet D, Valiquette L, et al. Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J Am Soc Nephrol. 1999;10:1007-1013.
Petrucci M, Scott P, Ouimet D, et al. Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis. Kidney Int. 2000;58:38-42.
Khullar M, Relan V, Singh SK. VDR gene and urinary calcium excretion in nephrolithiasis. Kidney Int. 2006;69:943.
Lerolle N, Coulet F, Lantz B, et al. No evidence for point mutations of the calcium-sensing receptor in familial idiopathic hypercalciuria. Nephrol Dial Transplant. 2001;16:2317-2322.
Reed BY, Heller HJ, Gitomer WL, et al. Mapping a gene defect in absorptive hypercalciuria to chromososme 1q23.3-q24. J Clin Endocrinol Metab. 1999;84:3907-3913.
Reed BY, Gitomer WL, Heller HJ, et al. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spine bone density. J Clin Endocrinol Metab. 2002;87:1476-1485.
Geng W, Wang Z, Zhang J, et al. Cloning and characterization of the human soluble adenylyl cyclase. Am J Physiol Cell Physiol. 2005;288:C1305-C1316.
Muller D, Hoenderop JGJ, Vennekens R, et al. Epithelial Ca channel (ECAC1) in autosomal dominant idiopathic hypercalciuria. Nephrol Dial Transplant. 2002;17:1614-1620.
Goodman HO, Holmes RP, Assimov DG. Genetic factors in calcium oxalate stone disease. J Urol. 1995;153:301-307.
Wright A, Charlesworth B, Rudan I, et al. A polygenic basis for late-onset disease. Trends Genet. 2003;19:97-106.
Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77-84.
Gambaro G, Vezzoli G, Casari G, et al. Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis. 2004;44:963-986.
Wang WYS, Barratt BJ, Clayton DG, et al. Todd JA. Genome-wide assocition studies: theoretical and practical concerns. Nature Rev Genet. 2005;6:109-118.
Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complelx genetic traits: practical considerations. Nature Rev Genet. 2002;3:1-7.
Soylemezoglu O, Ozkaya O, Gonen S, et al. Vitamin D receptor gene polymorphism in hypercalciuric children. Pediatr Nephrol. 2004;19:724-727.
Rendina D, Mossetti G, Viceconti R, et al. Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients. Urology. 2004;64:833-838.
Relan V, Khullar M, Singh SK, et al. Association of vitamin D receptor genotypes with calcium excretion in nephrolithiatic subjects in northern India. Urol Res. 2004;32:236-240.
Vezzoli G, Soldati L, Proverbio MC, et al. Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones. J Nephrol. 2002;15:158-164.
Sugiyama T, Wang JC, Scott DK, Granner DK. Transcriptionactivation by the orphan nuclear receptor, chicken ovalbumin upstream promoter-trascription factor I (COUP-TFI). J Biol Chem. 2000;275: 3446-3454.
Vezzoli G, Tanini A, Ferrucci L, et al. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol. 2002;13:2517-2523.
Vezzoli G, Terranegra A, Arcidiacono T, et al. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int. 2007;71:1155-1162.
Corbetta S, Eller-Vainicher C, Filopanti M, et al. The A990G polymorphism of calcium sensing receptor gene (CaSR) is associated with nephrolithiasis in patients with primary hyperparathyroidism (PHPT). Eur J Endocr. 2006;155:687-692.
Terranegra A, Arcidiacono T, Biasion R, et al. Calcium-sensing receptor (CaSR), a candidate gene for calcium kidney stone disease. Nephrol Dial Transplant. 2006;21(suppl 4):292.
Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest. 2003;111:602-605.
Gao B, Yasui T, Itoh Y. Association of osteopontin gene haplotypes with nephrolithiasis. Kidney Int. 2007;72:592-598.
Suzuki Y, Pasch A, Bonny O, et al. Gain of function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Hum Mol Genet. 2008;17(11):1613-8.
Chen WC, Wu HC, Chen HY, et al. Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones. Urol Res. 2001;29:321-324.
Tsai FJ, Lin CC, Lu HF, et al. Urokinase gene 3’-UTR T/C polymorphism is associated with urolithiasis. Urology. 2002;59:458-461.
Tsai FJ, Wu HC, Chen HY, et al. Association of E-cadherin gene 3-UTR C/T polymorphism with calcium oxalate stone disease. Urol Int. 2003;70:278-281.
Chen WC, Chen HY, Wu HC, et al. Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease. Urol Res. 2003;31:218-222.
Freedman ML, Reich D, Penney KL, et al. Assessing the impact of population stratification on genetic association studies. Nat Genet. 2004;36:388-993.
Jiang Z, Asplin JR, Evan AP, et al. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet. 2006;38:474-478.
Cao G, Yang G, Timme TL, et al. Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis. Am J Pathol. 2003;162:1241-1248.
Weinman EJ, Mohanlal V, Stoycheff N, et al. Longitudinal study of urinary excretion of phosphate, calcium, and uric acid in mutant NHERF-1 null mice. Am JPhysiol Renal Physiol. 2006;290:F838-843.
Mo L, Liaw L, Evan AP, et al. Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsf all protein, or both. Am J Physiol Renal Physiol. 2007;293:F1935-1943.
Chau H, El-Maadawy S, McKee M, et al. Renal calcification in mice homozygous for the disrupted type Iia Na/Pi cotransporter gene Npt2. J Bone Miner Res. 2003;18:64-657.
Lorenz-Depiereux B, Benet-Pages A, Eckstein G, et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet. 2006;78:193-201.
Gupta A, Tenenhouse HS, Hoag HM, et al. Identification of the type II Na+–Pi cotransporter (Npt2) in the osteoclast and the skeletal phenotype of Npt2−/− mice. Bone. 2001;29:467-476.
Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nature Rev Genet. 2007;8:253-262.
Robertson KD. DNA metilation and human disease. Nature Rev Genet. 2005;6:597-610.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer London
About this chapter
Cite this chapter
Gambaro, G., Soldati, L., Vezzoli, G. (2010). Genetics and Molecular Biology of Renal Stones. In: Rao, N., Preminger, G., Kavanagh, J. (eds) Urinary Tract Stone Disease. Springer, London. https://doi.org/10.1007/978-1-84800-362-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-84800-362-0_2
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84800-361-3
Online ISBN: 978-1-84800-362-0
eBook Packages: MedicineMedicine (R0)